APA (7th ed.) Citation

Xicota, L., Lecoeur, A., Gyorgy, B., Danjou, F., Fontaine, G., Epelbaum, S., . . . Potier, M. (2020). P.213 Specific polygenic risk scores discriminate asymptomatic at-risk individuals according to their brain amyloid load. European Neuropsychopharmacology, 31, S28. https://doi.org/10.1016/j.euroneuro.2019.12.039

Chicago Style (17th ed.) Citation

Xicota, L., et al. "P.213 Specific Polygenic Risk Scores Discriminate Asymptomatic At-risk Individuals According to Their Brain Amyloid Load." European Neuropsychopharmacology 31 (2020): S28. https://doi.org/10.1016/j.euroneuro.2019.12.039.

MLA (9th ed.) Citation

Xicota, L., et al. "P.213 Specific Polygenic Risk Scores Discriminate Asymptomatic At-risk Individuals According to Their Brain Amyloid Load." European Neuropsychopharmacology, vol. 31, 2020, p. S28, https://doi.org/10.1016/j.euroneuro.2019.12.039.